Registry-based Clinical Trials Can Dramatically Slash Both Time and Cost to Complete Studies Involving New Therapeutic Drugs and Medical Laboratory Tests

Mar 19, 2014 | Coding, Billing, and Collections, Compliance, Legal, and Malpractice, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology

New approach to clinical trials promises to make it faster and cheaper to do meaningful clinical studies, thus benefiting pharma firms and in vitro diagnostics manufacturers There’s a new approach to clinical trials that helps shorten the time required to gain regulatory approval of new therapeutic drugs and in vitro diagnostic tests, while slashing the costs of a clinical trial by as much as 90%. This could end up being an important trend for clinical laboratories and pathology groups to...
;